Cipla inks investment pact with FIL Capital Investments

30 Nov 2015 Evaluate

Cipla has inked an investment pact with FIL Capital Investments (Mauritius) II for its consumer healthcare business. The investment is subject to approvals from the Foreign Investment Promotion Board (FIPB) and the Competition Commission of India (CCI), and the transfer of Cipla’s consumer healthcare business to Cipla Health.

In July, Cipla’s board had approved an investment by Fidelity Growth Partners India and US-based Fidelity Biosciences, through FIL Capital Investments (Mauritius) II or its affiliates in its recently launched consumer healthcare business.

Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 150 countries. Its portfolio includes 1500 plus products across therapeutic categories with one quality standard globally. 

Cipla Share Price

1503.05 -7.85 (-0.52%)
01-Jan-2026 10:23 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1713.15
Dr. Reddys Lab 1251.40
Cipla 1503.05
Zydus Lifesciences 908.55
Lupin 2083.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×